Compare ARIA to:
After Hours: 2.27 N/A (N/A) 1:20pm ET
| Last Trade: | 2.20 |
|---|---|
| Trade Time: | Nov 27 |
| Change: | |
| Prev Close: | 2.29 |
| Open: | 2.23 |
| Bid: | N/A |
| Ask: | 2.33 x 1000 |
| 1y Target Est: | 5.00 |
| Day's Range: | 2.20 - 2.31 |
|---|---|
| 52wk Range: | 0.72 - 3.48 |
| Volume: | 605,263 |
| Avg Vol (3m): | 2,568,640 |
| Market Cap: | 239.71M |
| P/E (ttm): | N/A |
| EPS (ttm): | -0.94 |
| Div & Yield: | N/A (N/A) |
| Mon, Nov 23 | Become a Recessionista? Not in This Stock MarketTradingMarkets.com |
| Mon, Nov 23 | ARIAD to Present Data on Pan-BCR-ABL Inhibitor AP24534 at 51st American Society of Hematology MeetingBusiness Wire |
| Fri, Nov 13 | ARIAD PHARMACEUTICALS INC FinancialsEDGAR Online Financials |
| Tue, Nov 10 | Bristol Licenses Arthritis Drug: BioBuzzat TheStreet.com |
| Tue, Nov 10 | ARIAD to Present at the Lazard Capital Markets 6th Annual Healthcare ConferenceBusiness Wire |
| Tue, Nov 10 | Celgene in the ASH Abstract Spotlight: BioBuzzat TheStreet.com |
| Tue, Nov 10 | Celgene in ASH Abstract Spotlight: BioBuzzat TheStreet.com |
| Mon, Nov 9 | ARIAD PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly ReportEDGAR Online |
| Mon, Nov 9 | Movers roundup: RadioShack, Abercrombie & FitchAP |
| Mon, Nov 9 | Doc Offers Top Hep C Drug Picks: BioBuzzat TheStreet.com |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.